Locations:
Search IconSearch

Heart, Vascular and Thoracic

Obstructive hypertrophic cardiomyopathy

REMS Update: Mavacamten Still Effective in Treating Real-World Patients With HCM

Few patients report left ventricular dysfunction or heart failure after one year

cardiac MRI showing obstructive hypertrophic cardiomyopathy

Final VALOR-HCM Report: At 128 Weeks, Mavacamten Sustains Gains in HCM Patients

Avoidance of septal reduction therapy continues while LVEF dysfunction remains infrequent

edge of an apolipoprotein particle

Small-Interfering RNA Shows Cumulative Lp(a) Reduction With Successive Doses

Phase 2 trial of zerlasiran yields first demonstration of longer effect with each dose of an siRNA

medical device deployed in the heart's left atrial appendage

LAA Occlusion Compares Favorably With Newer Oral Anticoagulants After AF Ablation

OPTION trial demonstrates significantly less bleeding risk with comparable efficacy

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

deployment of balloon aortic valvuloplasty device in the heart

Outcomes of Contemporary Therapy for Cardiogenic Shock Due to Severe Aortic Stenosis

Aortic valve replacement is best option for lowering mortality in this high-risk population

occluded pulmonary vein on angiography

Adding Drug-Coated Balloon Angioplasty to Stenting Reduces Pulmonary Vein Restenosis

Novel approach outperforms standard of care for post-PVI stenosis and occlusion

echocardiograms showing heart valve disease

Structural Valve Imaging Summit Returns With State-of-the-Art Program, Abundant Expert Interaction

27th offering of this CME favorite to be held March 6-9 in Hollywood, Florida

stylized heart and lungs with text overlay

Vitals: Outcomes in Adult Cardiac Surgery and Ischemic and Vascular Disease

A graphical recap of our recent data from some key cardiovascular areas

heller myotomy operation

Heller Myotomy for Esophageal Achalasia: 15-Year Freedom From Reintervention Is > 80%

25-year series of over 1,000 patients reveals good long-term palliation, esophageal preservation

Illustration of lungs, liver and kidneys
October 30, 2024/Transplant

Case Report: A Triple-organ Transplant for Comorbidities of Alpha-1 Antitrypsin Deficiency

First-ever procedure restores patient’s health

BackPage 1 of 104Next

Advertisement

Ad